Rohit GuptaPapers & abstracts
Brain tumor classification, DNA methylation profiling and cancer genomics. This list updates itself from my ORCID record.
18peer-reviewed papers
679citations
13h-index
Citation counts from OpenAlex for the papers listed here. * equal contribution. Also on Google Scholar and ORCID. Updated October 3, 2026.
2025
- DNA Methylation-Based Classification of Kidney Neoplasms
- Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma
- Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses
2023
- Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs
- “De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade
- Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis
2022
- EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma
- Intracranial mesenchymal tumors with FET‐CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas
- Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1
2021
2020
- The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma
- Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor
- Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition
- Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features
Conference abstracts (5)
2024
- DNA mutation sequencing and methylation analysis of somatic NF1 mutant IDH-wildtype glioblastoma identifies three epigenetic groups and CDKN2A/B loss as a negative prognostic biomarker
- Single-cell RNA (scRNA) sequencing of paired primary and recurrent atypical teratoid/rhabdoid tumors (AT/RT) revealed molecular differences and therapy-resistant primary tumor cells